HS-729 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HS-729 cell line, originating from human bone and associated with embryonal rhabdomyosarcoma, serves as a critical tool in cancer research. This cell line is derived from a highly malignant and aggressive form of cancer that primarily affects skeletal muscle tissue, often in pediatric patients. The study of HS-729 cells allows researchers to delve into the molecular mechanisms and genetic alterations that drive the development and progression of embryonal rhabdomyosarcoma. Such insights are invaluable for the identification of potential therapeutic targets and the development of novel treatment strategies. HS-729 cells exhibit characteristics typical of rhabdomyosarcoma, including expression of muscle-specific markers and a propensity for rapid proliferation. They provide a model system for testing the efficacy of anti-cancer drugs and understanding drug resistance mechanisms. Additionally, HS-729 cells are instrumental in the study of tumor microenvironment interactions, metastatic behavior, and the role of various signaling pathways in cancer progression. Despite the limited specific information available about HS-729, cell lines of this nature remain indispensable in the ongoing battle against cancer, offering hope for more effective and targeted treatments in the future. |
|---|---|
| Organism | Human |
| Tissue | Bone |
| Disease | Embryonal rhabdomyosarcoma |
| Synonyms | Hs 729, Hs 729.T, Hs729, HS729, Hs-729-T, Hs 729T, Hs729T, HS729T |
Characteristics
| Age | 74 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Fibroblast-like |
| Growth properties | Monolayer, adherent |
Regulatory Data
| Citation | HS-729 (Cytion catalog number 300443) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0871 |
Biomolecular Data
| Isoenzymes | G6PD, B |
|---|
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|